Clinical trial
Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in…
NCT00217737 · National Cancer Institute (NCI), NIH · Active, not recruiting
Key facts
| NCT number | NCT00217737 |
|---|---|
| Title | Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer |
| Official title | A Randomized Phase III Study Comparing 5-FU, Leucovorin and Oxaliplatin Versus 5-FU, Leucovorin, Oxaliplatin and Bevacizumab in Patients With Stage II Colon Cancer at High Risk for Recurrence to Determine Prospectively the Prognostic Value of Molecular Markers |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Active, not recruiting |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Colon Adenocarcinoma, Stage IIA Colon Cancer AJCC v7, Stage IIB Colon Cancer AJCC v7, Stage IIC Colon Cancer AJCC v7 |
| Intervention type | Biological, Drug |
| Interventions | Bevacizumab, Fluorouracil, Leucovorin, Oxaliplatin |
| Enrollment | 2,431 |
| Start date | Sep 6, 2005 |
| Primary completion | Feb 22, 2024 |
| Completion | Apr 11, 2026 |
| First posted | Sep 22, 2005 |
| Last update posted | Dec 3, 2025 |
| Countries | Canada, Peru, Puerto Rico, South Africa, United States |
At a glance
- 1,000+ Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: